4.7 Article

Prevention of arthritis by interleukin 10-producing B cells

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 197, Issue 4, Pages 489-501

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20021293

Keywords

autoimmunity; immunoregulation; B cells; interleukin 10; CD40

Funding

  1. Arthritis Research UK [17707] Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

In this study we have shown that activation of arthritogenic splenocytes with antigen and agonistic anti-CD40 gives raise to a B cell population that produce high levels of interleukin (IL)-10 and low levels of interferon (IFN)-gamma. Transfer of these B cells into DBA/1-TcR-beta-Tg mice, immunized with bovine collagen (CII) emulsified in complete Freund's adjuvant inhibited T helper type 1 differentiation, prevented arthritis development, and was also effective in ameliorating established disease. IL-10 is essential for the regulatory function of this subset of B cells, as the B cells population isolated from IL-10 knockout mice failed to mediate this protective function. Furthermore, B cells isolated from arthritogenic splenocytes treated in vitro with anti-IL-10/anti-IL-10R were unable to protect recipient mice from developing arthritis. Our results suggest a new role of a subset of B cells in controlling T cell differentiation and antoimmune disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available